Lurasidone Hydrochloride Tablet, Coated
Product Images NDC 65162-882
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 65162-882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Lurasidone HCl Tablets 2)
This is a list of drugs and their impact on Lurasidone Pharmacokinetics (PK). The drugs listed include a Strong CYP3A4 Inhibitor, Ketoconazole at 400 mg per day, a Moderate CYP3A4 Inhibitor, Diltazem at 240 mg per day, and a Strong CYP3A4 Inducer, Rifampin at 600 mg per day, and Lithium at 600 mg BID. The impact on PK is measured using Cmax and Auc values and presented as a Fold Change with 90% CI.*
2 (Lurasidone HCl Tablets 3)
This appears to be a table or chart of some sort with headings related to medications and dosages. It includes drug names such as Digonin and Norcgestromin, along with their dosages. It also references "CYPIAL Substrates" and "Orul Comracepive" but without additional context it is unclear what these are. The chart appears to show a "Fold Change and 90% CI" with numbers ranging from 0.05 to 10. However, without further information it is difficult to determine what this represents.*
3 (Lurasidone HCl Tablets 4)
20 (Lurasidone HCl Tablets 5)
40 (Lurasidone HCl Tablets 6)
60 (Lurasidone HCl Tablets 7)
80 (Lurasidone HCl Tablets 8)
120 (Lurasidone HCl Tablets 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.